Evaluation of the Potential Effects of Intra-Articular Rifamycin SV Injection into the Knee Joint on Articular Cartilage and Synovial Membrane

ArticleAçık Erişim

Özet

Introduction: Rifamycin is widely used as a broad-spectrum antimicrobial agent; recent studies have demonstrated the anti-inflammatory properties of rifamycin SV. Our study aimed to determine the adverse effects of intra-articular injection of rifamycin SV on the articular cartilage and synovial membrane of the knee joint. Methods: Thirty-two Wistar albino male rats were assigned to experimental and control groups (n=8 per group). On the first day, a single dose of 5mg/kg rifamycin SV (Rif; Koçak Farma, Türkiye) was injected into the right knee of the rats in the experimental groups (E1/E2), and a single dose of 0.9% isotonic sodium solution was injected into the right knee of the rats in the control groups (C1/C2). E1 and C1 rats were euthanized on the 7th day, and E2 and C2 rats were euthanized on the 28th day. Macroscopic and histopathological evaluations of the articular cartilage structures and synovial inflammation were performed. The histopathological grading and staging system of the Osteoarthritis Research Society International was used to evaluate the cartilage structures, with p<0.05 considered statistically significant. Results: There were no statistically significant differences between the E1 and C1 groups or between the E2 and C2 groups in cartilage damage degree, stage, or score on the 7th day (p=0.117, p=0.197, p=0.197) and on the 28th day (p=0.077, p=0.061, p=0.062). When the E1 and C1 groups were examined to determine degrees of synovial inflammation, inflammation was significantly more common in the rifamycin SV (E1) group (p<0.001 on day 7). In contrast, degrees of synovial inflammation did not differ significantly between the E2 and C2 groups (p=0.256, day 28). Conclusion: The intra-articular administration of rifamycin SV did not have a negative effect on articular cartilage but increased synovial inflammation on the 7th day. ©Copyright 2026 by the University of Health Sciences Türkiye, İstanbul Training and Research Hospital/İstanbul Medical Journal published by Galenos Publishing House.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/10282Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorBilgin, Yücel
dc.contributor.authorÖzkök, Elif
dc.contributor.authorCin, Merve
dc.contributor.authorBirişik, Fevzi
dc.contributor.authorDoğan, Ibrahim
dc.contributor.authorKalyenci, Ahmet Sinan
dc.date.accessioned2026-10-18T20:25:31.364801275Z
dc.date.available2026-10-18T20:25:31.364801275Z
dc.date.issued2026
dc.description.abstractIntroduction: Rifamycin is widely used as a broad-spectrum antimicrobial agent; recent studies have demonstrated the anti-inflammatory properties of rifamycin SV. Our study aimed to determine the adverse effects of intra-articular injection of rifamycin SV on the articular cartilage and synovial membrane of the knee joint. Methods: Thirty-two Wistar albino male rats were assigned to experimental and control groups (n=8 per group). On the first day, a single dose of 5mg/kg rifamycin SV (Rif; Koçak Farma, Türkiye) was injected into the right knee of the rats in the experimental groups (E1/E2), and a single dose of 0.9% isotonic sodium solution was injected into the right knee of the rats in the control groups (C1/C2). E1 and C1 rats were euthanized on the 7th day, and E2 and C2 rats were euthanized on the 28th day. Macroscopic and histopathological evaluations of the articular cartilage structures and synovial inflammation were performed. The histopathological grading and staging system of the Osteoarthritis Research Society International was used to evaluate the cartilage structures, with p<0.05 considered statistically significant. Results: There were no statistically significant differences between the E1 and C1 groups or between the E2 and C2 groups in cartilage damage degree, stage, or score on the 7th day (p=0.117, p=0.197, p=0.197) and on the 28th day (p=0.077, p=0.061, p=0.062). When the E1 and C1 groups were examined to determine degrees of synovial inflammation, inflammation was significantly more common in the rifamycin SV (E1) group (p<0.001 on day 7). In contrast, degrees of synovial inflammation did not differ significantly between the E2 and C2 groups (p=0.256, day 28). Conclusion: The intra-articular administration of rifamycin SV did not have a negative effect on articular cartilage but increased synovial inflammation on the 7th day. ©Copyright 2026 by the University of Health Sciences Türkiye, İstanbul Training and Research Hospital/İstanbul Medical Journal published by Galenos Publishing House.
dc.identifier.doi10.4274/imj.galenos.2026.62257
dc.identifier.eissn2148-094X
dc.identifier.endpage232
dc.identifier.issn2619-9793
dc.identifier.issue3
dc.identifier.scopus2-s2.0-105047480348
dc.identifier.startpage225
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/10282
dc.identifier.volume27
dc.identifier.wosWOS:001841253200001
dc.language.isoen
dc.publisherGalenos Publishing House
dc.relation.ispartofIstanbul Medical Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectcartilage
dc.subjectisotonic sodium chloride
dc.subjectknee
dc.subjectRifamycin
dc.subjectantiinfective agent
dc.subjecteosin
dc.subjectfibrin
dc.subjecthematoxylin
dc.subjecthydrochloric acid
dc.subjectisotonic solution
dc.subjectketamine
dc.subjectsodium chloride
dc.subjectthiopental
dc.subjectxylazine
dc.subjectadult
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectarticular cartilage
dc.subjectbody weight
dc.subjectcontrolled study
dc.subjectdrug efficacy
dc.subjecteffect size
dc.subjectfemale
dc.subjecthistology
dc.subjecthistopathology
dc.subjecthyperplasia
dc.subjectintraarticular drug administration
dc.subjectknee joint
dc.titleEvaluation of the Potential Effects of Intra-Articular Rifamycin SV Injection into the Knee Joint on Articular Cartilage and Synovial Membrane
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus0
rdl.citation.trdizin0
rdl.citation.wos0
rdl.departmentSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
rdl.departmentBURSA ULUDAĞ ÜNİVERSİTESİ
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.departmentİSTANBUL ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.wos.indexEmerging Sources Citation Index (ESCI)